Typically my blogs include interesting observations from our partners in EMEA, who are changing the way we look at content management through industry and business solutions (see list of EMEA partner blogs, below). Today, I want to salute some of our key EMC Certified Solution partners for the innovative ways they are addressing customer challenges.
On behalf of my team, I’m proud to announce the winners of our Partner Innovation Awards for EMEA. These awards recognize partners for Continue reading →
Collaboration and Efficiency through Smarter Information Management
The waves outside my hotel room window are unpredictable. Yet surfers float, awaiting the next big ride.
Similarly, nobody can tell where the next inspiration for major new drug innovations mightstart. We do know that getting approval to market drug innovations is paramount for Life Sciences survival. And we know content management can create the right “swell” to buoy any business swimming in documentation.
2014 Predicts Data Revelations & Better Usability in the Life Sciences Sector
In our last blog, we revealed how cost pressures are forcing a dramatic reinvention across Life Sciences business models, with many customers using technology innovations to gain efficiencies and contain costs. We also showed how closer partnerships in the sector will make new collaboration models contagious and more prevalent.
Now we add our next two predictions for 2014 and beyond, and continue to welcome your thoughts and comments further below to continue the dialogue.
An Industry of Discoverers
This prediction could be tied back to cost pressures, but we have found our science-heavy industry is inherently also a curious one. We believe the analytical and research-oriented minds in Life Sciences will readily act on big data for big discoveries.
2014 Predicts Dramatic Change in the Life Sciences Industry
More than many of the industries EMC enables through technology, Life Sciences is evolving in dramatic fashion. Almost as breakthrough as the drug delivery shift from swallowed tablets to stick-on patches, the industry’s business model is also changing its form.
As our first two 2014 predictions relate (more to come in our next blog), with these kind of numbers, it won’t be business as usual in Life Sciences moving forward.
1 – Efficiency First
For our first prediction, we foresee a fanatic focus on driving efficiencies in pharmaceutical research and development, including the clinical development process.
Why is it our top priority prediction? Primarily because the historical model of developing drugs simply cannot be maintained any longer. Overly time-consuming or capital-heavy development just can’t be supported at the other end of the market – buyer-side, or through the pricing at which pharmaceuticals are sold.
Life Sciences customers will need to implement smart, efficient best practices to survive, by leveraging technology innovations. Rather than developing Continue reading →
The trend in the industry is unmistakable where enterprise customers are seeking a model in which vendors are incentivized to ensure success of the solution through its lifetime. The old model of dropping application software and leaving town is increasingly being frowned upon. Is this the revival of the dreaded “O” word – outsourcing? Yes, but I can assure the readers that it is not your father’s outsourcing though. It is a relationship that is based on deep application and solution specific expertise. This is in sharp contrast to a relationship that was based on the promise of lower cost, built largely on labor cost arbitrage. It is clear now that, Continue reading →